AJJ Medtech & Autagco Partner to Deploy Humanoid Elderly Care Robots in Singapore

The partnership brings together AJJ Medtech’s strengths in humanoid robotics, artificial intelligence, and digital health with Autagco’s operational experience in elderly care.

Medical equipment distributor AJJ Medtech Holdings and assisted living services provider Autagco have entered into a legally binding memorandum of understanding (MOU) to co-develop, deploy, and commercialize humanoid elderly care robots across Autagco’s assisted living facilities in Singapore.

The partnership brings together AJJ Medtech’s strengths in humanoid robotics, artificial intelligence, and digital health with Autagco’s operational experience in elderly care.

The collaboration aims to transform Autagco’s centres into AI-powered intelligent care environments, setting a new standard for scalable and high-quality elderly care services.

As part of the initiative, Autagco will acquire six units of AJJ-HT-X1 humanoid robots for deployment within its facilities. Clinical trials and operational applications will be conducted on-site to assess safety, effectiveness, and functional capabilities, including companionship, rehabilitation support, health monitoring, and cognitive engagement.

“We are pleased to enter into this strategic MOU with Autagco for the clinical trials, which marks the next phase in the development and operation of the world’s first multifunctional humanoid robot. We will capitalise on our expertise in digital healthcare, product know-how and understanding of Singapore’s healthcare and regulatory requirements to bring this collaboration forward,” said Alice Zhao Xin, executive director and CEO of AJJ Medtech, in a November 13 announcement.

Autagco’s executive chairman and CEO, Ng Boon Hui, added, “The strategic partnership with AJJ Medtech will elevate Autagco’s level of care services, transforming our service delivery model for our assisted living clients. We are excited to work with AJJ Medtech to bring this collaboration into fruition.”

The MOU, valid for 36 months starting November 12, may be renewed upon mutual agreement.

Shares of AJJ Medtech were trading 0.1 cent lower, or 9.09% down, at 1 cent, while Autagco’s shares remained unchanged at 0.3 cent.

Stay tuned for more such updates on Digital Health News